Navigation Links
PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
Date:5/27/2009

e earliest phases of clinical development through the approval process and into post-marketing."

PAREXEL has experience across a broad range of cancer indications as well as all classes of therapeutics including cytotoxics, biologics, targeted therapies, immunotherapies, vaccine therapies, and supportive treatments, such as blood products, growth factors, antiemetics, and analgesics. PAREXEL's Hematology/Oncology Therapeutic Area Team offers expertise to help clients with every facet of drug development, including protocol review, safety assessment, clinical development, medical imaging, technology integration, regulatory affairs, and product lifecycle management. Comprehensive services provided by the team include the planning, design, and management of feasibility studies, Phase I - IV trials, and post-marketing studies as well as site selection, patient recruitment, data analysis, non-clinical evaluation, and IND/NDA submissions. PAREXEL leverages the experience and relationships its experts have with leading cancer centers and key opinion leaders in its ongoing collaborative efforts.

PAREXEL applies a proven, therapeutically focused expertise methodology to clinical development programs across a broad range of areas. For more information about PAREXEL's in-depth expertise in the oncology, central nervous system (CNS), cardiovascular, infectious disease therapeutic areas, as well as a broad range of other therapeutic areas, visit: http://www.parexel.com/clinical_research/therapeutic_expertise.html.

Information about the ASCO Annual Meeting can be found at: http://www.asco.org/annualmeeting'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
2. PAREXEL Expands Global Clinical Pharmacology Capabilities
3. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
4. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
5. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
6. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
7. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
8. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
9. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
10. Genmab Reaches Milestone in Ofatumumab Collaboration
11. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... YORK , Oct. 22, 2014 Sanomedics ... August 2014 report by Global Research & Data Services, ... per year from 2014 through 2018, as demand for ... States is the world,s largest market for ... with advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... 22, 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... the  IAP310 study have been published in ... peer-reviewed journal with broad, multidisciplinary readership. IAP310 was ... safety and efficacy of Zalviso, also referred to ... the treatment of post-operative pain in patients following ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
... SCOLR Pharma, Inc. (OTC Bulletin Board: SCLR ... & Company, a company providing complete support services to ... pharmaceutical companies, distributors and retailers that are interested in ... prescription pharmaceutical or nutritional products.   With ...
... Feb. 25, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... be held March 1 - 3, 2011 at the Hilton New ... be held March 2 - 3, 2011 at the New York ... 31st Annual Healthcare Conference to be held March 7 - 9, ...
Cached Medicine Technology:SCOLR Pharma, Inc. Retains Nicholas Hall & Company 2Pharmasset to Present at Three Upcoming Investor Conferences 2Pharmasset to Present at Three Upcoming Investor Conferences 3
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 During the ... fresh water supply runs dangerously low, Southern Oregon’s water ... Oregon’s rivers, despite the lowest mountain snow pack on ... late summer and early autumn.* That was the observation ... the new book “Hiking Southern Oregon,” during an interview ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
(Date:10/22/2014)... By Maureen Salamon ... -- A crucial part of conventional in vitro fertilization (IVF) ... can instead take place in a device inside the vagina, ... Colombia contend that the device, called an INVOcell, might sharply ... could also make the technology more accessible to those who ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... still received high-quality care , WEDNESDAY, June 3 (HealthDay ... should reassure patients and the doctors who treat them. ... patients whose condition is complex may not get the ... Laura Peterson. "Doctors are concerned that under pay-for-performance there ...
... global leader in overseas health care facilitation, launches its online ... , The exclusive website is custom-built for existing and potential ... world seeking accessible and affordable first-rate health care solutions. ... more reachable and viable for consumers underlies the intuitive design ...
... Care Needs; Economic uncertainty and increased longevity add urgency , ... to live longer in retirement than past generations, and the ... has never been more critical. However, many people avoid bringing ... members, primarily because of a reluctance to accept what may ...
... study provides the first direct evidence that our mood literally ... suggesting that seeing the world through rose-coloured glasses is more ... change the way our visual cortex operates and how we ... psychology. "Specifically our study shows that when in a ...
... Football Hall-of-Famer Mike Ditka, one of the most popular figures ... of this month,s episode of Sharing Miracles -- ... and inspirational stories of real patients. Sharing Miracles ... nationwide. Known for his flamboyant style, "Da Coach" is ...
... : The National Infertility Association honored Reproductive Medicine Associates ... with The 2009 Friends of RESOLVE Award at their Annual Night ... program recognizes individuals and practices who have been devoted to assisting ... RESOLVE in helping the 7.3 million people in the U.S. build ...
Cached Medicine News:Health News:Pay-for-Performance Doesn't Shortchange Patients 2Health News:Pay-for-Performance Doesn't Shortchange Patients 3Health News:Veiovis Launches Medical Travel Web Portal 2Health News:Veiovis Launches Medical Travel Web Portal 3Health News:Video: Plan for Long Term Care Before the Crisis Hits 2Health News:Video: Plan for Long Term Care Before the Crisis Hits 3Health News:Video: Plan for Long Term Care Before the Crisis Hits 4Health News:People who wear rose-colored glasses see more, University of Toronto study shows 2Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 2Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 3Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 4Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 5Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 6Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 7Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 8Health News:National Infertility Organization Honors RMA of New York for Community Support 2
... of macular health. Snellen charts ... 20/20). Easy to mount on ... performed in a few minutes. ... patients. Retinal vision testing without ...
Non-mydriatic stereo fundus camera for glaucoma detection at early stage....
Eye Q SuperLite is ideal for color and red-free imaging used in general clinical and optometric casework such as anterior segmenting and diabetic screening....
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
Medicine Products: